Increased synovial expression of nuclear receptors correlates with protection in pristane-induced arthritis: A possible novel genetically regulated homeostatic mechanism

Arthritis and Rheumatism

Volumn 63, Issue 10, 2011, Pages 2918-2929

  Brenner, Max ^a   Linge, Carl P ^a   Li, Wentian ^a   Gulko, Pércio S ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER X RECEPTOR ALPHA; MATRIX METALLOPROTEINASE 14; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRISTANE; RETINOID X RECEPTOR GAMMA; STROMELYSIN; VITAMIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE LOCUS; GENETIC REGULATION; HOMEOSTASIS; HYBRIDIZATION; INNATE IMMUNITY; JOINT DEGENERATION; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; RNA EXTRACTION; SYNOVIUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; IMMUNITY, INNATE; INTERLEUKIN-1BETA; INTERLEUKIN-6; JOINTS; MALE; MATRIX METALLOPROTEINASES; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SYNOVIAL MEMBRANE; TERPENES; UP-REGULATION;

EID: 80053516910     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30507     Document Type: Article

References (50)

1. Seldin MF, Amos CI, Ward R, Gregersen PK,. The genetics revolution and the assault on rheumatoid arthritis [review]. Arthritis Rheum 1999; 42: 1071-9. (Pubitemid 29268942)
2. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 481-94. (Pubitemid 24115934)
3. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis: a genomewide study. N Engl J Med 2007; 357: 1199-209. (Pubitemid 47443179)
4. Gregersen PK, Amos CI, Lee AT, Lu Y, Remmers EF, Kastner DL, et al. REL, encoding a member of the NF-κB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet 2009; 41: 820-3.
5. Van Zeben D, Breedveld FC,. Prognostic factors in rheumatoid arthritis. J Rheumatol Suppl 1996; 44: 31-3. (Pubitemid 26094644)
6. Gossec L, Dougados M, Goupille P, Cantagrel A, Sibilia J, Meyer O, et al. Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis 2004; 63: 675-80. (Pubitemid 38658397)
7. Wolfe F, Rasker JJ, Boers M, Wells GA, Michaud K,. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis. Arthritis Rheum 2007; 57: 935-942. (Pubitemid 47237319)
8. Meng HC, Griffiths MM, Remmers EF, Kawahito Y, Li W, Neisa R, et al. Identification of two novel female-specific non-major histocompatibility complex loci regulating collagen-induced arthritis severity and chronicity, and evidence of epistasis. Arthritis Rheum 2004; 50: 2695-705. (Pubitemid 39062733)
9. Brenner M, Laragione T, Mello A, Gulko PS,. Cia25 on rat chromosome 12 regulates severity of autoimmune arthritis induced with pristane and with collagen. Ann Rheum Dis 2007; 66: 952-7. (Pubitemid 46999800)
10. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G,. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004; 10: 175-81. (Pubitemid 38524888)
11. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610-5. (Pubitemid 36297546)
12. Batliwalla FM, Li W, Ritchlin CT, Xiao X, Brenner M, Laragione T, et al. Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis. Mol Med 2005; 11: 21-9.
13. Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG, et al. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005; 52: 430-41. (Pubitemid 40216307)
14. Vingsbo C, Sahlstrand P, Brun J, Jonsson R, Saxne T, Holmdahl R,. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996; 149: 1675-83. (Pubitemid 26363973)
15. Brenner M, Meng HC, Yarlett NC, Griffiths MM, Remmers EF, Wilder RL, et al. The non-major histocompatibility complex quantitative trait locus Cia10 contains a major arthritis gene and regulates disease severity, pannus formation, and joint damage. Arthritis Rheum 2005; 52: 322-32. (Pubitemid 40129265)
16. Laragione T, Brenner M, Mello A, Symons M, Gulko PS,. The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts. Arthritis Rheum 2008; 58: 2296-306.
17. Taberner M, Scott KF, Weininger L, Mackay CR, Rolph MS,. Overlapping gene expression profiles in rheumatoid fibroblast-like synoviocytes induced by the proinflammatory cytokines interleukin-1β and tumor necrosis factor. Inflamm Res 2005; 54: 10-6. (Pubitemid 40385336)
18. Vincenti MP, Brinckerhoff CE,. Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1β. Arthritis Res 2001; 3: 381-8. (Pubitemid 33077119)
19. Dasu MR, Hawkins HK, Barrow RE, Xue H, Herndon DN,. Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 2004; 202: 476-85. (Pubitemid 38456166)
20. Schopf L, Savinainen A, Anderson K, Kujawa J, DuPont M, Silva M, et al. IKKβ inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis. Arthritis Rheum 2006; 54: 3163-73. (Pubitemid 44622087)
21. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, et al. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A 1998; 95: 13859-64. (Pubitemid 28523063)
22. 2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. J Clin Invest 2000; 106: 189-97. (Pubitemid 30483122)
23. Chintalacharuvu SR, Sandusky GE, Burris TP, Burmer GC, Nagpal S,. Liver X receptor is a therapeutic target in collagen-induced arthritis. Arthritis Rheum 2007; 56: 1365-7. (Pubitemid 46608662)
24. Afif H, Benderdour M, Mfuna-Endam L, Martel-Pelletier J, Pelletier JP, Duval N, et al. Peroxisome proliferator-activated receptor γ1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1β in articular chondrocytes. Arthritis Res Ther 2007; 9: R31.
25. Kim MS, Sweeney TR, Shigenaga JK, Chui LG, Moser A, Grunfeld C, et al. Tumor necrosis factor and interleukin 1 decrease RXRα, PPARα, PPARγ, LXRα, and the coactivators SRC-1, PGC-1α, and PGC-1β in liver cells. Metabolism 2007; 56: 267-79. (Pubitemid 46084934)
26. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK,. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 1998; 391: 79-82. (Pubitemid 28079218)
27. Li-Hawkins J, Lund EG, Turley SD, Russell DW,. Disruption of the oxysterol 7α-hydroxylase gene in mice. J Biol Chem 2000; 275: 16536-42. (Pubitemid 30398877)
28. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P,. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003; 9: 213-9. (Pubitemid 36227724)
29. Park MC, Kwon YJ, Chung SJ, Park YB, Lee SK,. Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatology (Oxford) 2010; 49: 882-90.
30. Asquith DL, Miller AM, Hueber AJ, McKinnon HJ, Sattar N, Graham GJ, et al. Liver X receptor agonism promotes articular inflammation in murine collagen-induced arthritis. Arthritis Rheum 2009; 60: 2655-65.
31. Hindinger C, Hinton DR, Kirwin SJ, Atkinson RD, Burnett ME, Bergmann CC, et al. Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis. J Neurosci Res 2006; 84: 1225-34. (Pubitemid 44654446)
32. A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009; 31: 245-58.
33. Delerive P, Monte D, Dubois G, Trottein F, Fruchart-Najib J, Mariani J, et al. The orphan nuclear receptor RORα is a negative regulator of the inflammatory response. EMBO Rep 2001; 2: 42-8. (Pubitemid 32229720)
34. sg/sg) mice to lipopolysaccharide-induced lung inflammation. Am J Physiol Lung Cell Mol Physiol 2005; 289: L144-52. (Pubitemid 40863564)
35. Wiesenberg I, Chiesi M, Missbach M, Spanka C, Pignat W, Carlberg C,. Specific activation of the nuclear receptors PPARγ and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608. Mol Pharmacol 1998; 53: 1131-8. (Pubitemid 28280458)
36. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, et al. Rev-erbα, a heme sensor that coordinates metabolic and circadian pathways. Science 2007; 318: 1786-9. (Pubitemid 350274391)
37. Szanto A, Benko S, Szatmari I, Balint BL, Furtos I, Ruhl R, et al. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol Cell Biol 2004; 24: 8154-66. (Pubitemid 39167464)
38. Szeto FL, Sun J, Kong J, Duan Y, Liao A, Madara JL, et al. Involvement of the vitamin D receptor in the regulation of NF-κB activity in fibroblasts. J Steroid Biochem Mol Biol 2007; 103: 563-6. (Pubitemid 46401357)
39. 3 inhibits type II collagen-induced arthritis in rats. FEBS Lett 1994; 337: 248-50.
40. Cantorna MT, Hayes CE, DeLuca HF,. 1,25-dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998; 128: 68-72. (Pubitemid 28087178)
41. Joosten LA, Helsen MM, Saxne T, van de Loo FA, Heinegard D, van den Berg WB,. IL-1αβ blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-α blockade only ameliorates joint inflammation. J Immunol 1999; 163: 5049-55. (Pubitemid 29501273)
42. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, et al. Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 1998; 187: 461-8. (Pubitemid 28093348)
43. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994; 37: 644-52. (Pubitemid 24145067)
44. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M,. Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 1989; 83: 585-92. (Pubitemid 19061181)
45. Marinova-Mutafchieva L, Williams RO, Mason LJ, Mauri C, Feldmann M, Maini RN,. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin Exp Immunol 1997; 107: 507-12. (Pubitemid 27102139)
46. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000; 191: 313-20. (Pubitemid 30060920)
47. Saijo S, Asano M, Horai R, Yamamoto H, Iwakura Y,. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. Arthritis Rheum 2002; 46: 533-44. (Pubitemid 34136592)
48. Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum 2000; 43: 1001-9. (Pubitemid 30368176)
49. Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, et al. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum 1998; 41: 2117-21. (Pubitemid 29009369)
50. Nishimoto N, Hashimoto J, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis 2007; 66: 1162-7. (Pubitemid 47309731)